Nervonik receives regulatory approval to start First-in-Human study with Novel Peripheral Nerve Stimulation Technology for Chronic Pain

Nervonik, a medical device startup focusing on neurotechnology approaches to peripheral nerve stimulation, has received approval to conduct a first-in-human feasibility study utilizing its proprietary technology. The focus will be on chronic pain of peripheral nerve origin, although the novel technology will eventually be utilized for a variety of medical indications.

Enrollment in the study is anticipated to begin later in the 3rd quarter of 2024 with presentation of results following.

LabNews Media LLC

LabNews: Biotech. Digital Health. Life Sciences. Pugnalom: Environmental News. Nature Conservation. Climate Change. augenauf.blog: Wir beobachten Missstände

Vollständige Bio ansehen